Images & VideoWhat if you could treat the disease and not just the symptoms? February 09, 2016
Learn about Neuropore’s two part development strategy targeting misfolded proteins -- the key pathological culprit(s) underlying neurodegenerative disorders.What is the future of Parkinson’s disease treatment? February 09, 2016
Learn about our lead molecule for Parkinson’s disease (PD), which directly interferes with the aggregation of alpha-synuclein – a key protein in the pathology underlying the progression of PD.Can normal cellular processes be used to fight neurodegenerative diseases? February 09, 2016
Learn about our efforts to target multiple molecular mechanisms of autophagy to facilitate the clearance of misfolded proteins.